Alexis N. Email & Phone Number

San Diego, CA, US

Leading the development of the Resiniferatoxin program focusing on value preservation, expanding portfolio indications, strengthening intellectual property, and establishing global merger and acquisition partnerships aimed at investment or joint venture opportunities. Driving strategic planning for the next phases of drug development, including Phase 3.

San Diego, CA, US

Providing consulting services to human life sciences and animal health companies, with a focus on guiding human life science organizations in assessing and planning the transition of innovative assets into the animal health sector. Assisting early-stage animal health companies in structuring their operations, preparing investor presentations, driving.

San Diego, California, US

Executive Leadership Team Member..Head of resiniferatoxin (RTX) human and animal health drug development program.Head of corporate development.BDL and IR functions as required.Special projects (business operations and program execution) as assigned by CEO.As Senior Vice President of Corporate Development and Head of the RTX Business Unit, spearheaded.

San Diego, California, US

Responsible for establishing the company's goals, strategies and execution of long-term vision as set by the board of directors. Provide adequate and timely information to the Board to enable it to effectively execute its oversight role. Oversee budgets and ensures resources are properly allocated. Direct staff, including organizational structure.

Poway, California, US

VetStem Biopharma (formerly Vet-Stem Inc.) was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held biotechnology enterprise, based near San Diego (California), offers veterinarians access to autologous adipose derived stem-cell therapy among other regenerative treatment modalities. As President and Chief.

Los Angeles, CA, US

Developed and executed strategic direction for marketing operations, overseeing P&L, budgets, branding, and tactical initiatives across 600 pet healthcare locations in 47 states, supporting 15,000 employees and generating over $1.4B in annual sales. Led a marketing team of 23 full-time staff and managed eight marketing agencies (100+ FTEs) within a tightly.

Rahway, New Jersey, US

Led the global re-evaluation, rebranding, and relaunch of the Zubrin® tablets initiative, strategically planning the future positioning of a “quality of life” product range from feasibility through development and market launch. Managed NSAID and chronic care product portfolios, including P&L oversight and brand repositioning in the U.S. Defined clinical.

Basel, Baselstadt, CH

Senior brand manager, InterceptorPromoted by the Global CEO to lead the Interceptor brand, focusing on strategic planning and sales initiatives for 2004 and 2005. Managed P&L responsibilities, including an $8M advertising and promotions budget, driving brand growth from $97M to $130M. Achieved a record-breaking milestone by capitalizing on the “Proheart6.

Topeka, KS, US

Managed all online and direct marketing initiatives, seamlessly integrating them with offline campaigns to drive retention, acquisition, and support for Petco's direct initiatives. Oversaw an e-marketing budget exceeding $2M, delivering over $6M in profit from direct campaigns in 2002. Achieved exceptional results, exceeding lead generation goals by 240%.

Co-founder and owner of a pioneering medical health data management company for pet owners and veterinarians. Designed and implemented the business model while overseeing marketing and sales operations in a 12-employee startup. Secured one international patent for an online medical record system for pets. Led two successful rounds of venture capital.

Libourne, FR

Managed "non-core" products, including intra-mammary and oral antibiotics, with a focus on European SKU rationalization, licensing, and special projects. Successfully licensed $2M in new products, doubling the $1M target. Optimized SKUs across Europe, achieving significant cost savings. Revitalized Swiss distribution operations, transforming a 15% annual.

FR

Diagnostics Business Unit Manager (Tampa, Florida):Established a new diagnostics department in the U.S. division, leading market analysis, USDA product registration, and product launch strategies. Secured regulatory approval for diagnostic imports in just three months (vs. the expected 14 months) and successfully launched three products within two years.